Ziemssen, T

Klotz, L; Berthele, A; Brück, W; Chan, Andrew; Flachenecker, P; Gold, R; Haghikia, A; Hellwig, K; Hemmer, B; Hohlfeld, R; Korn, T; Kümpfel, T; Lang, M; Limmroth, V; Linker, R A; Meier, U; Meuth, S G; Paul, F; Salmen, Anke; Stangel, M; ... (2016). [Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]. Der Nervenarzt, 87(6), pp. 645-659. Springer 10.1007/s00115-016-0077-1

Sehr, T; Proschmann, U; Thomas, K; Marggraf, M; Straube, E; Reichmann, H; Chan, Andrew; Ziemssen, T (2016). New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies. Journal of neuroinflammation, 13(1), p. 164. BioMed Central 10.1186/s12974-016-0635-2